Casdin Capital »

Denali Therapeutics shares owned by Casdin Capital

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Casdin Capital from 13F filings

Historical chart of Casdin Capital investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Casdin Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Casdin Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $29M 990k 29.13
2024-06-30 $30M 1.3M 23.22
2024-03-31 $27M 1.3M 20.52
2023-12-31 $28M 1.3M 21.46
2023-09-30 $27M 1.3M 20.63
2023-06-30 $38M 1.3M 29.51
2023-03-31 $30M 1.3M 23.04
2022-12-31 $36M 1.3M 27.81
2022-09-30 $31M 995k 30.69
2022-06-30 $44M 1.5M 29.43
2022-03-31 $48M 1.5M 32.17
2021-12-31 $67M 1.5M 44.60
2021-09-30 $86M 1.7M 50.45
2021-06-30 $126M 1.6M 78.44
2021-03-31 $92M 1.6M 57.10
2020-12-31 $110M 1.3M 83.76
2020-09-30 $47M 1.3M 35.83
2020-06-30 $32M 1.3M 24.18
2020-03-31 $26M 1.5M 17.51
2019-12-31 $22M 1.3M 17.42
2019-09-30 $8.3M 400k 20.76
2019-06-30 $8.3M 400k 20.76
2019-03-31 $2.3M 100k 23.22
2018-12-31 $2.1M 100k 20.66